We’ve recently updated our valuation analysis.

Acotec Scientific Holdings Valuation

Is 6669 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score


Valuation Score 4/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 6669?

Other financial metrics that can be useful for relative valuation.

6669 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue4.2x
Enterprise Value/EBITDA95.6x
PEG Ration/a

Price to Sales Ratio vs Peers

How does 6669's PS Ratio compare to its peers?

6669 PS Ratio vs Peers
The above table shows the PS ratio for 6669 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average11.4x
2190 Zylox-Tonbridge Medical Technology
2235 MicroTech Medical (Hangzhou)
1696 Sisram Medical
9996 Peijia Medical
6669 Acotec Scientific Holdings

Price-To-Sales vs Peers: 6669 is good value based on its Price-To-Sales Ratio (7.4x) compared to the peer average (11.4x).

Price to Earnings Ratio vs Industry

How does 6669's PE Ratio compare vs other companies in the HK Medical Equipment Industry?

Price-To-Sales vs Industry: 6669 is expensive based on its Price-To-Sales Ratio (7.4x) compared to the Hong Kong Medical Equipment industry average (3.9x)

Price to Sales Ratio vs Fair Ratio

What is 6669's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

6669 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio7.4x
Fair PS Ratio18.4x

Price-To-Sales vs Fair Ratio: 6669 is good value based on its Price-To-Sales Ratio (7.4x) compared to the estimated Fair Price-To-Sales Ratio (18.4x).

Share Price vs Fair Value

What is the Fair Price of 6669 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 6669 (HK$8.85) is trading below our estimate of fair value (HK$14.35)

Significantly Below Fair Value: 6669 is trading below fair value by more than 20%.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies